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Pharmacological studies were performed in mice on the methanol extract of
Tinospora crispa (TC), and of its hexane (HF) and chloroform (CF) fractions. Significant
antinociceptive activity was observed for TC, HF, and CF in the acetic acid-induced
writhing and formalin-induced paw licking tests. Anxiolytic and antidepressant activi-
ties were assessed using the open field, hole board, and elevated plus maze (EPM)
tests. TC, HF, and CF demonstrated a significant decrease in spontaneous locomotor
activity. They also showed an increase in the number of head-dippings in the hole-
board test, suggesting decreased fearfulness. TC, and most of its fractions, showed a
significant increase of the time spent in the opened arm of the EPM, indicating
reduced anxiety. This study provides some support to explain the traditional use of T.
crispa as a remedy for pain.
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1 | INTRODUCTION
Tinospora crispa (L.) Hook. f. & Thomson (Menispermaceae) is an her-
baceous vine with large heart-shaped leaves and small greenish yel-
low-colored flowers that grows commonly in the forests of South East
Asia and Africa (Pathak, Jain, & Sharma, 1995). The plant is used in
traditional medicine to treat a range of ailments, including to relieve
inflammation, fever, and muscle pain (Khare, 2008; Kongsaktrakoon,
Temsiririrkkul, Suvitayavat, Nakornchai, & Wongkrajang, 1984;
Roosita, Kusharto, Sekiyama, Fachrurozi, & Ohtsuka, 2008). In Bangla-
desh, the plant is known as “Gulancha” (Ahmad, Jantan, &
Bukhari, 2016). It is used as a tonic and blood purifier, and for intesti-
nal disorders, jaundice, leprosy, fever, rheumatism, and pain (Ahmad
et al., 2016; Yusuf, Chowdhury, Wahab, & Begum, 1994). T. crispa
contains some flavonoids, sterols, terpenoids, alkaloids, and lignans.
Its extracts and/or isolated compounds have demonstrated anti-
inflammatory, immunomodulatory, cytotoxic, antioxidant, anti-
nociceptive, antipyretic, hepatoprotective, antimalarial,
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hypoglycaemic, antifilarial, and cardioprotective activities (Ahmad
et al., 2016; Rakib et al., 2019). Another species of Tinospora (T. cor-
difolia) has been shown to exhibit sedative and anxiolytic effects
(Barua et al., 2019; Mishra et al., 2016).
Pain is an unpleasant feeling—usually associated with tissue dam-
age caused by noxious stimuli, inflammation, and disease processes—
that can often be chronic (Hylands-White, Duarte, & Raphael, 2017;
May et al., 2017). The management of pain mainly relies on the use of
analgesics such as paracetamol, non-steroidal anti-inflammatory drugs
(NSAIDs), and opioids, all of which present some significant adverse
side effects (Carter et al., 2014). Other drugs, that can be prescribed,
include adjuvants, such as anxiolytics that help reduce pain-related
anxiety, and antidepressants that help to manage the depressive state
encountered in chronic pain conditions and provide analgesia by inter-
fering with the endogenous pain control mechanisms (Hylands-White
et al., 2017). Unfortunately, many of the current anxiolytics and anti-
depressants exhibit some undesirable side effects too, which contrib-
ute to poor patient compliance (David & Gourion, 2016; Slee
et al., 2019). There is a need to explore other sources, such as medici-
nal plants, for the discovery of new potential drug leads (Fajemiroye,
Da Silva, De Oliveira, & Costa, 2016). This study was undertaken to
assess the antinociceptive, anxiolytic, and antidepressant activity of
the methanol extract of T. crispa (TC) and two of its fractions, namely
the n-hexane fraction (NH) and the chloroform fraction (CF), in order
to better understand the use of this plant in traditional medicine.
2 | MATERIALS AND METHODS
2.1 | Plant collection
The whole plant of T. crispa was collected at the mature stage from
the Lawachara National Park, Moulavi Bazar, Bangladesh, in January
2018. The parts of the plant were cut into small pieces that were
washed under tap water and then dried in the dark at 21–30C for
15 days. The whole plant material was ground by a mechanical grinder
and passed through a size of 60 mesh sieve to obtain a fine powder
that was stored in an air-tight container.
2.2 | Preparation of extracts
The dried T. crispa plant powder (600 g) was macerated in methanol (4
L) for 15 days at room temperature with occasional shaking and stir-
ring. Following filtration, first with a cotton plug then with a Whatman
no. 1 filter paper, the filtrate was evaporated to dryness under vac-
uum at 40C to obtain a concentrated extract (30.55 g dry weight,
5.09% w/w). The methanolic extract of T. crispa whole plant (TC) was
further fractionated using n-hexane and chloroform to obtain two
fractions of (HF) and (CF), respectively. All extracts, fractions, and
standards used in the in vivo tests were suspended in normal saline
using dimethyl sulfoxide (DMSO) at the highest concentration of 1
and 1% Tween-80.
2.3 | Chemicals and reagents
Methanol, n-hexane, chloroform, formalin, and acetic acid were pur-
chased from Merck (Darmstadt, Germany). Diclofenac sodium and
diazepam (DZP) were purchased from Eskayef Bangladesh Ltd. (Tongi,
Bangladesh). Normal saline solution (0.9% NaCl) was obtained from
Orion Infusion Ltd. (Tejgaon, Bangladesh). DMSO and Tween-80 were
from BDH Chemicals (Leicestershire, UK). All other chemicals were of
analytical grade and were obtained either from BDH Fluka Chemie
GmbH (Buchs, Switzerland) or Merck (Darmstadt, Germany).
2.4 | Experimental animals
Swiss albino mice (weighing 25–30 g, aged 4–5 weeks), of either sex,
were used throughout the study. They were collected from the animal
laboratory at Jahangirnagar University, Dhaka-1342, Bangladesh. The
animals were kept in groups of five in a controlled laboratory environ-
ment (12-hr dark/12-hr light cycle; temperature 25 ± 2C) for 7 days
for acclimatization. The animals were given standard feed and water
ad libitium. The animals fasted overnight and were weighed before the
experiment. The design and performance of the research study involv-
ing mice were permitted by the Ethical Review Committee of the Fac-
ulty of Biological Science, University of Chittagong through the
submission of a research protocol before the study, and ethical per-
mission (Pharmacol/DPH/UC/01, 2018) was obtained.
2.5 | Acute toxicity studies
This was accomplished according to the OECD guidelines (OECD
Guidelines, 2002). The test animals were abstained overnight prior to
the experiment and continued under standard laboratory conditions.
The animals were randomly chosen and divided into groups (n = 5)
which were orally administered different increasing the doses (up to
2,000 mg/kg) of TC, HF, and CF. The control group received 1%
Tween 80 in water (p.o.). The animals were kept under observation
for 24 hr to record the general signs and symptoms of toxicity. The
mortality rate was recorded for each group at the end of this period.
2.6 | Antinociceptive activity
2.6.1 | Acetic acid-induced writhing test
Peripheral analgesic activity was studied by observing the writhing
response (i.e., contractions of the abdominal muscles and stretching of
the hind limbs) of mice following the intraperitoneal administration of
acetic acid (Koster, 1959). Forty experimental mice were randomly
selected and divided into eight groups (n = 5). Normal saline with 1%
DMSO (0.1 ml/10 g body weight, negative control), diclofenac sodium
(100 mg/kg, positive control), TC, HF, and CF (at doses of 200 and
400 mg/kg) were administered per os (p.o.) to the animals 40 min prior
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to the intraperitoneal administration of acetic acid (0.7%, 0.1 ml/10 g
body weight). The 40-min interval was set to ensure the proper
absorption of the administered samples. Five minutes after the admin-
istration of acetic acid, each animal was isolated in an individual obser-
vation chamber, and the cumulative number of writhing responses
was recorded for 10 min. The percentage inhibition of writhing in
comparison to the negative control group was taken as an index of
analgesia and was calculated using the following formula:
Inhibition %ð Þ= Wc−Wtð Þ=Wcf g×100,
where Wc is the average number of writhing reflex in the control
group, and Wt is the average number of writhing in the test groups.
2.6.2 | Formalin-induced paw licking test
This was carried out according to a previous methodology (Okokon
& Nwafor, 2010). Animals were divided into eight groups (five mice
per group). A 2.5% formalin solution in saline (20 μl) was injected
subcutaneously to a hind paw of mice 30 min after the subcutaneous
administration of diclofenac sodium (10 mg/kg) (Positive control,
Group 2), and of TC, HF, and CF (200 and 400 mg/kg, p.o.) (Test
Group 3 to 10). The negative control group (Group 1) received only
the 2.5% solution of formalin in normal saline (20 μl). The time spent
licking and biting the injected paw was taken as an indicator of the
response to pain, and the data were expressed as the total licking
time in the early phase (0–5 min) and the late phase (15–30 min)
after formalin injection. The percentage of inhibition of pain was
determined using the following equation for early- and late-
phase pain:
Inhibition %ð Þ= TLc –TLtð Þ=TLcf g×100,
where TLc is the average time spent licking in the control group, and
TLc is the average time spent licking in the test groups.
2.7 | Anxiolytic and antidepressant activity
2.7.1 | Open field test
This was conducted to evaluate the spontaneous locomotor activity
of mice using an open field apparatus (Rauniar, Deo, &
Bhattacharya, 2007). Forty animals were divided into eight groups
(n = 5). The negative control group received a 1% Tween-80 solu-
tion in water (10 ml/kg; p.o). The test group was administered TC,
HF, and CF (200 and 400 mg/kg, p.o.) and the positive control
group received diazepam (1 mg/kg, i.p.). The mice were placed
inside a box (50 cm × 50 cm × 40 cm h) with a floor separated into
a series of lines forming 25 squares consecutively colored black
and white. The number of crossed lines passed by each animal was
counted for 3 min at 0, 30, 60, 90, 120 min during the study period.
Different groups were used for different evaluation times. The per-
centage inhibition of movements was calculated as;
Inhibition %ð Þ= Mc−Mtð Þ=Mcf g×100,
where Mc is the average number of movements in the control
group, and Mt is the average number of movements in the test
groups.
2.7.2 | Hole board test
The study was conducted using a wooden board, measuring 20 cm by
40 cm with 16 evenly spaced holes (Sonavane, Sarveiya, Kasture, &
Kasture, 2002). The animals were randomly divided into eight groups
(five mice per group). The control group was treated with 1% Tween
80 (10 ml/kg, p.o.). The examined mice were treated with TC, HF, and
CF (200 and 400 mg/kg), while those in the positive control group
received diazepam (1 mg/kg). Thirty minutes after the treatment, the
mice were placed singly on the board, and the number of times the
mice dipped their head into the holes at the level of their eyes during
a 5-min trial period was counted using a tally counter.
2.7.3 | Elevated plus maze test
The elevated plus maze (EPM) consisted of two opened arms (35 × 5
cm) crossed with two closed arms (35 × 20 cm). The arms were con-
nected together with a central square (5 × 5 cm). The apparatus was
elevated to a height of 25 cm in a dimly illuminated room. The ani-
mals, divided into 8 groups (n = 5 in each group), were treated with
TC, HF, and CF (200 and 400 mg/kg, p.o.), and diazepam (1 mg/kg, i.
p., positive control) or normal saline (negative control) 30 min before
being placed individually in the center of the EPM, facing a closed
arm. The time spent in both the opened and closed arms was recorded
for 5 min (Pellow & File, 1986).
2.7.4 | Statistical analysis
The results obtained were expressed as mean ± SEM of five animals.
For statistical analysis, one-way analysis of variance ANOVA followed
by post-hoc Dunnett's test, was used to compare the test samples with
the negative control. Effects were considered to be significant at the p
< .05 level. The statistical analysis was carried out using SPSS v.16.0.
3 | RESULTS
3.1 | Acute toxicity studies
No lethal effects were observed within the 24 hr, following the
administration of TC, HF, and CF, even at the highest dose of 2,000
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mg/kg. With that in mind, dose levels of 200 and 400 mg/kg were
selected for the present study.
3.2 | Antinociceptive activity
3.2.1 | Acetic acid-induced writhing test
The methanol extract of T. crispa dose-dependently induced a signifi-
cant (p < .01) decrease in the number of writhes with 51.48 and
54.89% of inhibition at doses of 200 and 400 mg/kg, respectively,
compared to the negative control. This was comparable to the stan-
dard drug, diclofenac (65.27% inhibition). The hexane fraction (HF)
derived from TC exhibited a comparable antinociceptive effect
(56.28% inhibition) which was significant (p < .01) at a dose of 400
mg/kg (Table 1).
3.2.2 | Formalin-induced paw licking test
TC exhibited a substantial and significant inhibition of licking
responses at both doses of 200 and 400 mg/kg compared to the neg-
ative control. At the dose of 400 mg/kg, it showed 57.37% inhibition
in the early phase (p < .001) and 56.43% (p < .01) in the late phase. At
a dose of 400 mg/kg, CF showed significant inhibition in the late
phase (64.36%) that was comparable to the standard drug, diclofenac
(69.45%) (Table 2).
3.3 | Anxiolytic and antidepressant activity
3.3.1 | Open field test
At doses of 200 and 400 mg/kg, TC demonstrated a dose-dependent
and significant decrease in locomotion in the test animals during the
experiment period, which was comparable to the effect of the stan-
dard drug, diazepam. Treatments with HF and CF at the same doses
also induced a significant decrease in locomotion (Table 3).
3.3.2 | Hole board test
TC-treated mice showed a significant increase in the number of head-
dipping compared to the negative control (46.05 and 83.51% at 200
and 400 mg/kg, respectively). The number of head-dipping also
increased significantly (p < .001) in DZP-treated mice compared to the
control, as did treatments with HF and CF at both doses. The highest
significant increase (73.54%, p < .01) was observed for CF at 400 mg/
kg (Table 4).
3.3.3 | Elevated plus maze (EPM) test
Diazepam significantly increased the time spent in the opened arm.
Mice treated with TC, HF, and CF, at doses of 200 and 400 mg/kg,
TABLE 1 Antinociceptive activity of TC, HF, and CF in the
acetic-acid induced writhing test in micea
Group
Number of
writhes
(mean ± SEM)
% of inhibition of
writhing
Control 28.73 ± 0.47 —
Standard
(diclofenac)
9.98 ± 0.46*** 65.27
TC (200 mg/kg) 13.94 ± 1.47** 51.48
TC (400 mg/kg) 12.96 ± 1.69** 54.89
HF (200 mg/kg) 15.35 ± 3.29** 46.57
HF (400 mg/kg) 12.56 ± 1.47** 56.28
CF (200 mg/kg) 20.56 ± 2.57 28.44
CF (400 mg/kg) 17.49 ± 2.78* 39.12
Abbreviations: CF, chloroform fraction; HF, hexane fraction; TC,
methanolic extract of T. crispa.
aValues are mean ± SEM (n = 5).
*p < .05, **p < .01 and ***p < .001 vs. control (one-way ANOVA followed
by Dunnett's test).
TABLE 2 Effects of TC, HF, and CF on the formalin-induced paw licking in micea
Group Early phase (0–5 min) % inhibition Late phase (15–30 min) % inhibition
Control 57.46 ± 1.38 — 41.32 ± 1.47 —
Standard (diclofenac) 14.68 ± 0.49*** 74.37 13.37 ± 0.48*** 69.45
TC (200 mg/kg) 35.35 ± 0.39** 35.32 26.91 ± 1.03** 36.57
TC (400 mg/kg) 25.47 ± 1.28*** 57.37 18.34 ± 0.437** 56.43
HF (200 mg/kg) 39.85 ± 1.29* 31.47 29.37 ± 0.46** 29.47
HF (400 mg/kg) 34.95 ± 1.38* 40.36 24.57 ± 0.91*** 42.67
CF (200 mg/kg) 39.36 ± 1.28* 32.47 20.34 ± 0.328* 51.46
CF (400 mg/kg) 33.23 ± 0.329** 42.58 15.57 ± 0.23** 64.36
Abbreviations: CF, chloroform fraction; HF, hexane fraction; TC, methanolic extract of T. crispa.
aValues are mean ± SEM (n = 5).
*p < .05, **p < .01 and ***p < .001 vs. control (one-way ANOVA followed by Dunnett's test).
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also showed a trend toward increased time spent in these arms,
although this did not reach significance for all treatments. The highest,
and significant, time increase vs. the negative control was observed
for CF at 200 mg/kg in the closed arm (p < .05) and TC at 400 mg/kg
(p < .001) in the opened arms (Table 5).
4 | DISCUSSION
Many medicinal plants are employed in traditional medicine world-
wide to relieve pain (Wirth, Hudgins, & Paice, 2005) and treat depres-
sion and anxiety (Sarris, Panossian, Schweitzer, Stough, &
Scholey, 2011). The present study was conducted to investigate the
antinociceptive, anxiolytic, and antidepressant effects of a methanolic
extract of Tinospora crispa (TC), and of its hexane (HF) and chloroform
(CF) fractions, using in vivo and in silico approaches. In order to sup-
port the traditional use of T. crispa for the relief of inflammation and
pain, peripheral antinociceptive activity was first evaluated using the
acetic acid-induced writhing test. The latter measures abdominal mus-
cle contractions (writhing) that are induced following the release of
inflammatory mediators, such as prostaglandins and bradykinins in
peripheral tissues (Sakiyama, Sujaku, & Furuta, 2008). The formalin-
induced paw licking test was also used to assess the analgesic activity.
In this test, formalin induces pain in two distinct phases that relate to
different nociceptive mechanisms (Dubuisson & Dennis, 1977). In the
early phase, formalin directly acts on the nociceptors and the pain can
be controlled with centrally acting analgesics. The late phase, on the
other hand, involves an inflammatory pain response that can be
inhibited by non-steroidal anti-inflammatory drugs such as diclofenac
(Clavelou, Dallel, Orliaguet, Woda, & Raboisson, 1995). We observed
that TC, HF, and CF showed significant antinociceptive activity in
both tests.
TABLE 4 Activity of TC, HF, and CF on the exploratory behavior
in the hole-board test in micea
Group Number of head-dipping % increase
Control 29.1 ± 0.75 —
DZP standard (1 mg/kg) 66.8 ± 1.30*** 127.15
TC (200 mg/kg) 42.5 ± 1.76* 46.05
TC (400 mg/kg) 53.4 ± 2.49** 83.51
HF (200 mg/kg) 33.6 ± 1.86** 15.46
HF (400 mg/kg) 44.9 ± 2.61*** 54.30
CF (200 mg/kg) 36.4 ± 1.57* 25.09
CF (400 mg/kg) 50.5 ± 2.30** 73.54
Abbreviations: CF, chloroform fraction; HF, hexane fraction; TC,
methanolic extract of T. crispa.
aValues are mean ± SEM (n = 5).
*p < .05, **p < .01 and ***p < .001 vs. control (one-way ANOVA followed
by Dunnett's test).
TABLE 3 Locomotor activity TC, HF, and CF in the open field test in micea
Group
Number of movements
0 min 30 min 60 min 90 min
Control 278.21 ± 4.85 284 ± 3.69 290.04 ± 4.20 298.56 ± 5.60
DZP standard 130.45 ± 5.62 125.65 ± 1.23*** 119.68 ± 3.45*** 115.56 ± 4.21***
TC (200 mg/kg) 152.46 ± 2.34 150.34 ± 1.45* 147.36 ± 1.34** 145.54 ± 0.32*
TC (400 mg/kg) 145.34 ± 1.39 143.46 ± 2.49** 142.56 ± 1.93** 140.36 ± 1.34***
HF (400 mg/kg) 149.34 ± 1.36 146.35 ± 1.64** 142.47 ± 1.47** 140.35 ± 1.73***
HF (200 mg/kg) 157.37 ± 2.74 153.57 ± 2.45** 150.36 ± 1.83* 147.35 ± 2.91*
CF (200 mg/kg) 155.79 ± 6.97 143.48 ± 2.65* 141.58 ± 3.15* 139.79 ± 5.26*
CF (400 mg/kg) 141.48 ± 8.12 135.58 ± 3.12** 133.78 ± 4.12** 122.84 ± 3.75**
Abbreviations: CF, chloroform fraction; HF, hexane fraction; TC, methanolic extract of T. crispa.
aValues are mean ± SEM (n = 5).
*p < .05, **p < .01 and ***p < .001 vs. control (one-way ANOVA followed by Dunnett's test).
TABLE 5 Anxiolytic activity of TC, HF, and CF in the EPM test in
micea
Group
Time spent in the
closed arm
Time spent in the
opened arm
Control 285.38 ± 1.47 10.17 ± 1.18
DZP Standard
(1 mg/kg)
246.45 ± 2.457** 48.36 ± 1.55***
TC (200 mg/kg) 265.38 ± 3.26* 29.36 ± 2.35**
TC (400 mg/kg) 252.37 ± 2.47** 41.237 ± 2.34***
HF (200 mg/kg) 275.38 ± 2.47 19.34 ± 2.55*
HF (400 mg/kg) 263.36 ± 2.346* 30.56 ± 2.43**
CF (200 mg/kg) 270.456 ± 2.47* 25.36 ± 2.46**
CF (400 mg/kg) 260.35 ± 3.36* 34.36 ± 2.43***
Abbreviations: CF, chloroform fraction; HF, hexane fraction; TC,
methanolic extract of T. crispa.
aValues are mean ± SEM (n = 5).
*p < .05, **p < .01 and ***p < .001 vs. control (one-way ANOVA followed
by Dunnett's test).
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The rationale for screening TC and its fractions for their activity
on the central nervous system (CNS) was based on the knowledge
that some sedative and anxiolytic effects had previously been
reported for another species of Tinospora (Barua et al., 2019; Mishra
et al., 2016). The open field test was used to measure the behavioral
and locomotor activity of mice (Tatem et al., 2014). Locomotor activ-
ity is considered an indicator of alertness, and any decrease in the
locomotor performance indicates a CNS-depressant effect (Gahlot,
Lal, & Jha, 2013; Hunskaar & Hole, 1987; Sousa et al., 2004). TC, and
its fractions, demonstrated a significant decrease in the locomotor
activity of animals, which may be as a result of interfering with the
neural mechanisms underlying locomotion (Côté, Murray, &
Knikou, 2018). In the hole-board test, which evaluates exploratory
behavior independently from locomotor activity, TC-treated mice
showed a significant increase in the number of head-dippings,
suggesting a decreased fearfulness (Brown & Nemes, 2008;
Crawley, 1985; Takeda, Tsuji, & Matsumiya, 1998). Anxiety disorders
are thought to originate from a dysregulation of a range of neuronal
systems, involving gamma-aminobutyric acid (GABA), serotonin, mela-
tonin, adrenalin, dopamine, glutamate, neuropeptides, and the endo-
cannabinoids (Murrough, Yaqubi, Sayed, & Charney, 2015) Anxiety-
like behavior was assessed in the elevated-plus maze (EPM) test (Rod-
gers, 1997). TC and most of its fractions showed a significant reduc-
tion in the time spent in the closed arm and increase of the time spent
in the opened arm, indicating reduced anxiety (Gagan, Richa,
Avninder, Sandeep, & Vivek, 2010).
It remains to be seen if the observed pharmacological effects are
attributable to the presence of any specific phytochemicals, although
it is worth mentioning that some previously isolated compounds in T.
crispa have demonstrated antinociceptive activity through interfering
with the release of nitric oxide, prostaglandin E2, and tumor necrosis
factor (TNF)-alpha (Choi et al., 2004; Yuanyuan, Yuan, &
Hongquan, 2010). This warrants further detailed investigation.
5 | CONCLUSION
We observed that the whole plant of TC exerted significant anti-
nociceptive, anxiolytic, and antidepressant activity on mice. This study
provides some support for the observed in vivo antinociceptive, anxi-
olytic, and antidepressant effects of this plant.
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